T. G. Zubkova

发表

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors

I. Tokin, D. Lioznov, T. G. Zubkova, 2020 .

Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine

D. Lioznov, S. Kharit, O. Gorchakova, 2018, Epidemiology and Vaccine Prevention.

[The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection].

I. Tokin, D. Lioznov, P. Sorokin, 2020, Terapevticheskii arkhiv.

Experience of etiotropic therapy of acute respiratory viral infection with domestic antiviral drug

I. Tokin, D. Lioznov, Yu.V. Drozdova, 2019, Infekcionnye bolezni.

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, The Lancet Regional Health - Europe.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

M. Stukova, D. Lioznov, R. Oseshnyuk, 2023, Vaccines.

[Evaluation of the effectiveness of ARVI treatment regimen including etiotropic (enisamium iodide) and symptomatic treatment].

D. Lioznov, T. G. Zubkova, E. J. Karnaukhova, 2020, Terapevticheskii arkhiv.

Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity

M. Shaw, H. Stammer, D. Boltz, 2020, Antimicrobial Agents and Chemotherapy.

An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, SSRN Electronic Journal.